An Open-Label Extension Study of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis ELEVATE UC OLE: An Open-Label Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Administered By

Awarded By

Contributors

Start/End

  • September 21, 2020 - September 27, 2023